Andrews, P (1985) Praziquantel: mechanisms of antischistosomal activity. Pharmacology & Therapeutics 29,129–156.
Badria, F et al. (2001) Mirazid: a new schistosomicidal drug. Pharmaceutical Biology 39, 127–131.
Bertão, HG et al. (2012) Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms. Parasitology Research 110, 2465–2473.
Bonn, D (2004) Schistosomiasis: a new target for calcium channel blockers? The Lancet Infectious Diseases 4, 190.
Botros, SS et al. (2005) Effect of praziquantel on the immature stages of Schistosoma haematobium. International Journal for Parasitology 3, 1453–1457.
Botros, SS et al. (2009) Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)- [3-hydroxy-2-(phosphonomethoxy) propyl adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro. Antimicrobial Agents and Chemotherapy 53, 5284–5287.
Brindley, PJ and Hotez, PJ (2013) Break out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era. PLoS Neglected Tropical Diseases 7, e1961.
Caffrey, CR (2015) Schistosomiasis and its treatment. Future Medicinal Chemistry 7, 675–676.
Cheever, AW (1968) Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bulletin of the World Health Organization 39, 328–331.
Cioli, D et al. (2014) Schistosomiasis control: praziquantel forever? Molecular and Biochemical Parasitology 195, 23–29.
Cohen, CJ, Spires, S and Van Skiver, D (1992) Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. General Physiology and Biophysics 100, 703–728.
Colley, DG et al. (2014) Human schistosomiasis. The Lancet 383, 2253–2264.
de Moraes, J et al. (2014) Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease schistosomiasis mansoni. PLoS Neglected Tropical Diseases 8, e2617.
Delgado, VS et al. (1992) Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitology Research 78, 648–654.
de Oliveira, RN et al. (2014) Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni. Experimental Parasitology 139, 63–72.
de Oliveira, RN et al. (2012) Schistosoma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. Experimental Parasitology 132, 135–143.
Doenhoff, MJ, Cioli, D and Utzinger, J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Current Opinion in Infectious Diseases 21, 659–667.
Duvall, RH and De Witt, WB (1967) Technique for recovering adult schistosomes from laboratory animals. The American Journal of Tropical Medicine and Hygiene 16, 438–486.
Frezza, TF et al. (2013) Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay. Acta Tropica 128, 70–75.
Frezza, TF et al. (2015) Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition. Acta Tropica 150, 182–189.
Greenberg, RM (2005) Are Ca2+ channels targets of praziquantel action? The International Journal for Parasitology 35, 1–9.
Greenberg, RM (2013) New approaches for understanding mechanisms of drug resistance in schistosomes. Parasitology 140, 1534–1546.
Hotez, PJ and Fenwick, A (2009) Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Neglected Tropical Diseases 3, e485.
Jiraungkoorskul, W et al. (2005) Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harbored in mice. Parasitology International 54, 177–183.
Kamel, ROA and Bayaumy, FEA (2017) Ultrastructural alterations in Schistosoma mansoni juvenile and adult male worms after in vitro incubation with primaquine. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro 112, 247–254.
Keiser, J et al. (2009) Mefloquine an aminoalcohol with promising antischistosomal properties in mice. PLoS Neglected Tropical Diseases 3, e350.
Kramer, CV et al. (2013) Drugs for treating urinary schistosomiasis. Cochrane Database of Systematic Reviews 2013, CD000053.
Liang, YS, John, BI and Boyd, DA (1987) Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proceedings of the 1st Sino-American Symposium 1, 34–48.
Li, S et al. (1996) Studies on prophylactic effect of artesunate on schistosomiasis japonica. Chinese Medical Journal (Engl) 109, 848–853.
Manneck, T, Haggenmuller, Y and Keiser, J (2010) Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137, 850–898.
Mitsui, Y, Miura, M and Aoki, Y (2009) In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni. Journal of Helminthology 83, 7–11.
Moraes, J (2012) Antischistosomal natural compounds: present challenges for new drug screens. In AJ, Rodriguez-Morales (ed.), Current Topics in Tropical Medicine. Rijeka: Intech, pp. 333–358.
Mostafa, OMS (2005) Effects of sedr honey and/or black-seed oil on Schistosoma mansoni in albino mice: parasitological, biochemical and scanning electron microscopical studies. The Egyptian Journal of Experimental Biology (Zoology) 45, 449–469.
Nessim, NG et al. (2000) Effect of the broad spectrum anthelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittel-Forschung 50, 1129–1133.
Neves, BJ et al. (2015) In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni. PLoS Neglected Tropical Diseases 9, e34–35.
Noël, F et al. (2001) Control of calcium homeostasis in Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz 96 (Suppl.), 85–88.
Oxford, AE, Raistrick, H and Simonart, P (1939) Studies in the biochemistry of micro-organisms: griseofulvin, C (17) H (17) O (6) Cl, a metabolic product of penicillium griseo-fulvum Dierckx. Biochemistry Journal 33, 240–248.
Pax, R, Bennett, JL and Fetterer, R (1978) A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn-Schmiedeberg's Archives of Pharmacology 304, 309–315.
Pellegrino, J et al. (1962) New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. The American Journal of Tropical Medicine and Hygiene 11, 201–215.
Pica-Mattoccia, L and Cioli, D (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. The International Journal for Parasitology 34, 527–533.
Ramirez, B et al. (2007) Schistosomes: challenges in compound screening. Expert Opinion on Drug Discovery 2, S53–S61.
Rathinasamy, K et al. (2010) Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine. Biomedcentral Cancer 10, 213.
Rebacz, B et al. (2007) Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Research 67, 6342–6350.
Redman, CA, Robertson, A and Fallon, PG (1996) Praziquantel: an urgent and exciting challenge. Parasitology Today 12, 14–20.
Riad, NH, Taha, HA and Mahmoud, YI (2009) Effects of garlic on albino mice experimentally infected with Schistosoma mansoni; a parasitological and ultrastructural study. Tropical Biomedicine 26, 40–50.
Rollinson, D et al. (2013) Time to set the agenda for schistosomiasis elimination. Acta Tropica 128, 423–440.
Salvador-Recatalà, V, Schneider, T and Greenberg, RM (2008) Atypical properties of a conventional calcium channel beta subunit from the platyhelminth Schistosoma mansoni. Biomedcentral Physiology 8, 6.
Shaohong, L et al. (2006) Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitology International 55, 63–68.
Shaw, MK and Erasmus, DA (1988) Schistosoma mansoni: praziquantel induced changes to the female reproductive system. Experimental Parasitology 65, 31–42.
Silva-Moraes, V et al. (2013) Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro 108, 600–604.
Singh, BN (1986) The mechanism of action of calcium antagonists relative to their clinical applications. British Journal of Clinical Pharmacology 21, 109S–121S.
Thetiot-Laurent, SA et al. (2013) Schistosomiasis chemotherapy. Agnewandte Chemie 52, 7936–7956.
Uen, YH et al. (2007) NF-kappa B pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells. Journal of Cellular Biochemistry 101, 1165–1175.
Vale, N et al. (2017) Praziquantel for schistosomiasis: single drug metabolism revisited, mode of action, and resistance. Antimicrobial Agents and Chemotherapy 61, e02582–16.
Walter, M and Kuris, A (2003) Methods for the inhibition of egg production in trematodes. USA patent 6,514,963. B2.
Wang, W, Wang, L and Liang, YS (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research 111, 1871–1877.
William, S, Guirguis, F and Nessim, NG (2003) Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. Arzneimittel-Forschung 53, 532–537.
Yang, Z et al. (2013) Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. Infection and Immunity 81, 1905–1914.